Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

University of Turku

Status: Active, not recruiting

Conditions: Atrial Fibrillation; Stroke, Ischemic

Treatments: Drug: Anticoagulation Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT04001205

T75/2019

Details and patient eligibility

About

This study explores the association of symptomatic episodes of atrial fibrillation (AF) occurrence and long-term risk of thromboembolic complications in a retrospective setting.

Full description

The study population consists of the FinCV-dataset, which includes 7660 acute cardioversions for atrial fibrillation. The electronic patient records of FinCV-study patients are reviewed to collect data on anticoagulation, number of cardioversions as well as mortality and stroke data. We seek to explore the possible association between the frequency of AF paroxysms in low stroke risk patients and the occurrence of death, stroke and major bleed as well as the net clinical benefit of anticoagulation. Data collection is performed by reviewing electronic patient records.

Enrollment: 1,300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• primary diagnosis of atrial fibrillation (ICD-10 code I48)
• Cardioversion for acute (<48 h) atrial fibrillation
• >18 years of age
• living within the catchment area of the hospital

Trial design

1,300 participants in 2 patient groups

No oral anticoagulation

Description:

Patients without oral anticoagulation for AF

Oral anticoagulation

Description:

Patients with long term oral anticoagulation

Treatment:

Drug: Anticoagulation Therapy